Inside Innovation

Fred Hutch Cancer Center and UW Medicine researchers Dr. Megan Shen and Dr. Mary L. “Nora” Disis were awarded $300,000 each by the Rivkin Center

Scientists from Seattle’s Allen Institute played a key role in accomplishing a feat that was said to be impossible 46 years ago: mapping the cells

Life Science Washington Institute (LSWI), in partnership with the Washington State Department of Commerce, announced the completion of the second and final year of the

Curi Bio, a Seattle-based biotech company, has settled into its new 13,942-square-foot space in Interbay. Founded in 2016, Curi Bio makes stem cell-based tissue models

The Allen Institute for AI (Ai2) is joining the Cancer AI Alliance, a national initiative led by Fred Hutch Cancer Center to accelerate cancer research

Researchers at Washington State University have developed a machine learning model that predicts which animal species are likely to host and transmit viruses, pinpointing potential

The Health Sciences & Services Authority (HSSA) of Spokane County awarded over $4.4 million in grants this winter to support bioscience innovation and expand healthcare

NIH funding is critical to maintaining American competitiveness and economic success. The Trump Administration’s proposed cuts to NIH’s indirect cost reimbursement threaten to undermine American

Cardiac Dimensions, a leader in minimally invasive heart failure treatments, raised $53 million in Series E funding to advance its Carillon Mitral Contour System for

LSW members Archon Biosciences, Fred Hutch Cancer Center, Talus Bioscience and Umoja Biopharma were named as finalists for GeekWire’s Health Innovation of the Year Award.

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round. Curevo’s efforts target shingles, a painful condition

Omeros received $4.02 million in funding from the National Institute on Drug Abuse (NIDA) for clinical development of its OMS527 program to treat cocaine use